Author:
Ebbers Meinolf,Hemmer Christoph J.,Müller-Hilke Brigitte,Reisinger Emil C.
Abstract
SummaryDue to the overuse of antibiotics, infections, in particular those caused by multidrug-resistant bacteria, are becoming more and more frequent. Despite the worldwide introduction of antibiotic therapy, vaccines and constant improvements in hygiene, the burden of multidrug-resistant bacterial infections is increasing and is expected to rise in the future. The development of monoclonal therapeutic antibodies and specific immunomodulatory drugs represent new treatment options in the fight against infectious diseases. This article provides a brief overview of recent advances in immunomodulatory therapy and other strategies in the treatment of infectious disease.
Funder
Universitätsmedizin Rostock
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Plotkin SA, Orenstein W, Offit P, Edwards KM. Plotkin’s vaccines. 7th ed. Amsterdam: Elsevier; 2018.
2. U.S. National Library of Medicine. History of medicine. 2019. https://www.nlm.nih.gov/exhibition/smallpox/sp_variolation.html. Accessed 27 Aug 2019.
3. Nardelli DT, Munson EL, Callister SM, Schell RF. Human Lyme disease vaccines: past and future concerns. Future Microbiol. 2009;4:457–69.
4. Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, et al. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci. 2019;116(37):18655–63.
5. Gorbalenya AE, Baker SC, Baric RS. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV‑2. Nat Microbiol. 2020;5:536–44.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献